Sio Gene Therapies Stock Operating Margin
| SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Sio Gene Therapies fundamentals help investors to digest information that contributes to Sio Gene's financial success or failures. It also enables traders to predict the movement of Sio Stock. The fundamental analysis module provides a way to measure Sio Gene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sio Gene stock.
Sio |
Sio Gene Therapies Company Operating Margin Analysis
Sio Gene's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Sio Gene Therapies has an Operating Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Sio Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sio Gene's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics of similar companies.Sio Gene is currently under evaluation in operating margin category among its peers.
Sio Fundamentals
| Return On Equity | -0.47 | |||
| Return On Asset | -0.24 | |||
| Current Valuation | (23.36 M) | |||
| Shares Outstanding | 73.98 M | |||
| Shares Owned By Insiders | 25.30 % | |||
| Shares Owned By Institutions | 26.82 % | |||
| Number Of Shares Shorted | 71.39 K | |||
| Price To Book | 0.54 X | |||
| EBITDA | (70.94 M) | |||
| Net Income | (71.89 M) | |||
| Cash And Equivalents | 54.77 M | |||
| Cash Per Share | 0.74 X | |||
| Total Debt | 2.36 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 6.46 X | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | (60.35 M) | |||
| Short Ratio | 0.11 X | |||
| Earnings Per Share | (0.38) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 12 | |||
| Beta | 1.49 | |||
| Market Capitalization | 30.63 M | |||
| Total Asset | 75.08 M | |||
| Z Score | 7.2 | |||
| Net Asset | 75.08 M |
About Sio Gene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sio Gene Therapies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |